Literature DB >> 8510772

Mechanisms of action of 7-O-ethyl tetrandrine in isolated vascular smooth muscle of the rabbit aorta.

J Y Su1.   

Abstract

Tetrandrine is an alkaloid from a Chinese herb which has been used to treat hypertension in humans. The mechanism(s) of its antihypertensive action is not clear. The goal of this study was to examine the direct effects of a derivative of tetrandrine, 7-O-ethyl tetrandrine (TD), on vascular smooth muscle. In particular, the goals were to study (1) the involvement of the endothelium in the responses of isolated aortic rings to TD, and (2) the effects of TD at intracellular sites involved in muscle contraction in skinned aortic strips treated with saponin. TD (1-100 mumol/l) decreased noradrenaline (NA) and K(+)-evoked contraction of isolated aortic rings with or without endothelium in a concentration-dependent manner although to a lesser degree with the K(+)-evoked contraction. In NA-contracted rings, the IC50 for TD was approximately 28-30 mumol/l, at which a 20% decrease in K(+)-force development of aortic rings was observed. The slope of the concentration-relaxation curve was steeper in aortic rings with endothelium than without endothelium (1.09 vs. 0.88) in NA-contracted rings. TD increased tone in acetylcholine (ACh)-relaxed rings but did not change the force in aortic rings relaxed by sodium nitroprusside (NaNP) or ATP. In TD pretreated rings, TD blocked ACh-induced relaxation, but not NaNP or ATP-induced relaxation. In skinned aortic strips, TD decreased Ca2+ uptake by the SR (IC50 approximately 77.4 mumol/l, slope = 0.88), did not affect Ca2+ release from the SR, and decreased Ca2+-activation of the contractile proteins at 300 mumol/l TD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8510772     DOI: 10.1007/BF00165397

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  13 in total

Review 1.  Cellular mechanisms regulating [Ca2+]i smooth muscle.

Authors:  C van Breemen; K Saida
Journal:  Annu Rev Physiol       Date:  1989       Impact factor: 19.318

Review 2.  The function of myosin and myosin light chain kinase phosphorylation in smooth muscle.

Authors:  K E Kamm; J T Stull
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

3.  Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin.

Authors:  V F King; M L Garcia; D Himmel; J P Reuben; Y K Lam; J X Pan; G Q Han; G J Kaczorowski
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

4.  A model-free approach to estimation of relative potency in dose-response curve analysis.

Authors:  V Guardabasso; D Rodbard; P J Munson
Journal:  Am J Physiol       Date:  1987-03

5.  Specific perforation of muscle cell membranes with preserved SR functions by saponin treatment.

Authors:  M Endo; M Iino
Journal:  J Muscle Res Cell Motil       Date:  1980-03       Impact factor: 2.698

6.  Mode of action of tetrandrine on vascular smooth muscle.

Authors:  W S Hu; X B Pang; Y Wang; C J Hu; F H Lü
Journal:  J Tradit Chin Med       Date:  1983-03       Impact factor: 0.848

7.  Structure and hypotensive activity relationships of tetrandrine derivatives in stroke-prone spontaneously hypertensive rats.

Authors:  K Kawashima; T Hayakawa; Y Miwa; H Oohata; T Suzuki; K Fujimoto; T Ogino; Z X Chen
Journal:  Gen Pharmacol       Date:  1990

8.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

9.  Kinetic disposition and hemodynamic effects of tetrandrine in anesthetized dogs.

Authors:  F D Zeng; D H Shaw; R I Ogilvie
Journal:  J Cardiovasc Pharmacol       Date:  1985 Nov-Dec       Impact factor: 3.105

10.  Decreased endothelium-dependent relaxation in New Zealand genetic hypertensive rats.

Authors:  R J Winquist; P B Bunting; E P Baskin; A A Wallace
Journal:  J Hypertens       Date:  1984-10       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.